| 2024-01-17 | Sale | Pliant Therapeutics, Inc. PLRX | Chief Business Officer | 9,786 0.0158% | $17.23 | $168,613 | -17.89% | |
| 2023-08-04 | Sale | Pliant Therapeutics, Inc. PLRX | Chief Business Officer | 20,050 0.0337% | $20.01 | $401,201 | -24.22% | |
| 2023-08-03 | Sale | Pliant Therapeutics, Inc. PLRX | Chief Business Officer | 14,869 0.0258% | $20.00 | $297,380 | -21.49% | |
| 2023-07-17 | Sale | Pliant Therapeutics, Inc. PLRX | Chief Business Officer | 17,937 0.0323% | $18.01 | $323,029 | -12.84% | |
| 2023-03-30 | Sale | Pliant Therapeutics, Inc. PLRX | Chief Business Officer | 9,036 0.0161% | $26.52 | $239,643 | -35.31% | |
| 2022-12-20 | Sale | Pliant Therapeutics, Inc. PLRX | Chief Business Officer | 8,748 0.018% | $19.10 | $167,108 | -0.58% | |
| 2022-12-20 | Sale | Pliant Therapeutics, Inc. PLRX | Chief Business Officer | 17,496 0.0359% | $19.10 | $334,216 | -0.58% | |
| 2015-06-04 | Sale | Adverum Biotechnologies, Inc. ADVM | SVP, Business Operations | 4,000 0.0076% | $18.92 | $75,663 | -78.25% | |
| 2015-05-04 | Sale | Adverum Biotechnologies, Inc. ADVM | SVP, Business Operations | 10,000 0.0196% | $15.53 | $155,299 | -70.81% | |
| 2015-04-07 | Sale | Adverum Biotechnologies, Inc. ADVM | SVP, Business Operations | 55,000 0.2139% | $38.60 | $2.12M | -75.42% |